Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

Encouraging Split Liver Transplantation for Two Adult Recipients to Mitigate the High Incidence of Wait-list Mortality in The Setting of Extreme Shortage of Deceased Donors.

Chan KM, Wang YC, Wu TH, Cheng CH, Lee CF, Wu TJ, Chou HS, Lee WC.

J Clin Med. 2019 Dec 1;8(12). pii: E2095. doi: 10.3390/jcm8122095.

2.

Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.

Chan KM, Wu TH, Cheng CH, Lee CF, Wu TJ, Chou HS, Lee WC.

Biomed J. 2019 Oct;42(5):335-342. doi: 10.1016/j.bj.2019.04.001. Epub 2019 Oct 29.

3.

Applicability of postoperative carcinoembryonic antigen levels in determining post-liver-resection adjuvant chemotherapy regimens for colorectal cancer hepatic metastasis.

Chiang JM, Hung HY, You JF, Chiang SF, Lee CF, Chou HS, Lee WC, Chan KM.

Medicine (Baltimore). 2019 Nov;98(44):e17696. doi: 10.1097/MD.0000000000017696.

4.

Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?

Lee CW, Tsai HI, Lee WC, Huang SW, Lin CY, Hsieh YC, Kuo T, Chen CW, Yu MC.

J Clin Med. 2019 Oct 19;8(10). pii: E1736. doi: 10.3390/jcm8101736.

5.

Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.

Lee WC, Chou HS, Wu TH, Cheng CH, Lee CF, Wang YC, Wu TJ, Chan KM.

Transpl Infect Dis. 2019 Oct 6:e13190. doi: 10.1111/tid.13190. [Epub ahead of print]

PMID:
31587427
6.

A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

Hsu SY, Yu HY, Lee WC, Hsiao CE, Wu CL, Cheng HT, Lin LJ, Li F, Chou YT, Cheng JW.

Onco Targets Ther. 2019 Sep 16;12:7611-7621. doi: 10.2147/OTT.S215824. eCollection 2019.

7.

Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival.

Chan KM, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Lee WC.

Cancer Manag Res. 2019 Aug 2;11:7295-7305. doi: 10.2147/CMAR.S215732. eCollection 2019.

8.

"Left at right" liver transplantation with heterotopic implantation of left liver graft in the right subphrenic space: Reappraisal and technical concerns for decision making.

Chan KM, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Lee WC.

Medicine (Baltimore). 2019 Jul;98(28):e16415. doi: 10.1097/MD.0000000000016415.

9.

Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables.

Xu D, Sheng JQ, Hu PJ, Huang TS, Lee WC.

J Biomed Inform. 2019 Aug;96:103237. doi: 10.1016/j.jbi.2019.103237. Epub 2019 Jun 22.

PMID:
31238108
10.

Coadministration of Erythromycin to Increase Tacrolimus Concentrations in Liver Transplant Recipients.

Chiang LH, Wu TH, Tsai TC, Lee WC.

Transplant Proc. 2019 Jun;51(5):1439-1441. doi: 10.1016/j.transproceed.2019.01.145.

PMID:
31155178
11.

The Transplantation Science Symposium Asian Regional Meeting 2018.

Lee WC.

Transplant Proc. 2019 Jun;51(5):1305. doi: 10.1016/j.transproceed.2019.05.005. No abstract available.

PMID:
31155173
12.

Sildenafil Monotherapy to Treat Portopulmonary Hypertension Before Liver Transplant.

Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC.

Transplant Proc. 2019 Jun;51(5):1435-1438. doi: 10.1016/j.transproceed.2019.01.139. Epub 2019 May 9.

PMID:
31079941
13.

Impact of donor with evidence of bacterial infections on deceased donor liver transplantation: a retrospective observational cohort study in Taiwan.

Chan KM, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Lee WC.

BMJ Open. 2019 Mar 23;9(3):e023908. doi: 10.1136/bmjopen-2018-023908.

14.

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma.

Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC.

Medicine (Baltimore). 2019 Mar;98(11):e14827. doi: 10.1097/MD.0000000000014827.

15.

Health-related quality of life of living liver donors 1 year after donation.

Weng LC, Huang HL, Lee WC, Tsai YH, Wang WS, Chen KH.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):1-9. doi: 10.21037/hbsn.2018.11.10.

16.

Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma.

Lee WC, Wang YC, Cheng CH, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM.

Sci Rep. 2019 Feb 19;9(1):2269. doi: 10.1038/s41598-019-38785-3.

17.

Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan.

Chan KM, Wu TH, Cheng CH, Lee CF, Wu TJ, Chou HS, Lee WC.

Cancer Manag Res. 2019 Jan 22;11:1013-1021. doi: 10.2147/CMAR.S186678. eCollection 2019.

18.

Crystal structure of the C-terminal domain of the primosomal DnaT protein: Insights into a new oligomerization mechanism.

Chen KL, Huang YH, Liao JF, Lee WC, Huang CY.

Biochem Biophys Res Commun. 2019 Mar 26;511(1):1-6. doi: 10.1016/j.bbrc.2019.02.026. Epub 2019 Feb 10.

PMID:
30755302
19.

Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation.

Chan KM, Wu TH, Cheng CH, Lee CF, Wu TJ, Chou HS, Lee WC.

J Gastrointest Surg. 2019 Feb 4. doi: 10.1007/s11605-019-04116-0. [Epub ahead of print]

PMID:
30719678
20.

A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation.

Tsai HI, Lo CJ, Zheng CW, Lee CW, Lee WC, Lin JR, Shiao MS, Cheng ML, Yu HP.

J Clin Med. 2018 Dec 29;8(1). pii: E30. doi: 10.3390/jcm8010030.

Supplemental Content

Loading ...
Support Center